Patients with AML had increased percentages of HSCs/CMPs [3], LSCs [1,2,10], GMPs [9] and CD34- progenitors [12,19] at the expense of granulocytes [5–7,18,29,32]. This evidence concerns the gene CD34 and acute myeloid leukemia.